CLINICAL TRIAL: CANDIDIASIS

临床试验：念珠菌病

• 批准号: 7717869
• 负责人: KRISA Page VAN MEURS
• 金额: $ 0.02万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7717869
• 关键词: Body Fluids; Candidiasis; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Diagnostic tests; Disease; Funding; Gold; Grant; Guidelines; Infant; Institution; Invasive; Modeling; Neonatal; Prospective Studies; Protocols documentation; Research; Research Personnel; Resources; Risk; Source; Sterility; Stratification; United States National Institutes of Health; attributable mortality; cohort; diagnosis standard; novel diagnostics; prospective

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Neonatal candidiasis is a lethal disease that is poorly understood. Despite an attributable mortality of 30%, the current gold standard for the diagnosis of neonatal candidiasis (repeated culture of normally sterile body fluid) has a sensitivity of 50%; and there have been no prospective studies to establish guidelines for the initiation of empirical treatment. This protocol will establish a prospective cohort of 1,750 infants born < 1000 grams birthweight in order to evaluate three new diagnostic tests and develop a risk stratification model for invasive candidiasis.

这个子项目是众多研究子项目之一